Abstract: The invention relates to the use of an extract of the fungus Inonotus obliquus for maintaining and/or increasing the cohesion of the skin tissues, for preventing the appearance of and/or for reducing shadows and/or bags in the area around the eyes, for maintaining and/or increasing the radiance and/or homogeneity of the skin complexion and/or for maintaining and/or increasing the barrier function of the skin and/or for increasing the skin microcirculation. The invention also relates to the extract of I. obliquus or a dermatological composition comprising same, for its use for reducing ruddiness and/or for preventing and/or reducing pathologies resulting from a reduction in the cohesion of the skin tissues, notably itching and/or couperosis.

Abstract: The present invention is a composition and method of treatment for fragile skin, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients such as but not limited to barrier repair ingredients such as but not limited to Skinmimics®, Retinol®, and glycolic acid; humectants such as but not limited to glycerin, propanediol, low and high molecular weight hyaluronic acids; redensifying agents such as but not limited to Timecode®, a lipo amino acid (palmitoyl glycine); and anti-inflammatory/anti-itch ingredients such as but not limited to soybean sterols, Timecode®, SymCalmin®, menthyl lactate, and niacinamide.

Abstract: The disclosure provides compositions and methods for promoting hair growth and reducing hair loss using bioactive extracts of curcumin, Withania somnifera, and saw palmetto. Tocotrienols, tocopherols, piperine extract, low molecular weight collagen, and hyaluronic acid are optionally included in the compositions and methods.

Abstract: A method of treating a person's skin is disclosed. The method can include topically applying to the skin a composition that includes an extract of Opuntia ficus-indica, water, caprylic/capric triglyceride, glycerin, Butyrospermum parkii (shea) butter, ammonium acryloyldimethyltaurate/vp copolymer, butylene glycol, ethylhexylglycerin, tocopherol or tocopheryl acetate, disodium EDTA, sodium hydroxide, caprylyl glycol, and Helianthus annuus (sunflower) seed oil.

Abstract: A usage of a Antrodia cinnamomea powder for preparation of a composition for dispelling the effects of alcohol, which means that by administering an effective amount of the Antrodia cinnamomea powder disclosed in the invention to an subject, is capable of accelerating metabolism of alcohol and/or acetaldehyde in the subject's body, reducing a content of alcohol and/or acetaldehyde in blood, and shortening the time of the subject generating intoxicated reaction in order to achieve an efficacy of dispelling the effects of alcohol.

Abstract: A cosmetic composition comprising, in a physiologically acceptable medium, at least: (1) a cosmetic agent consisting of galactomannans with molar masses of 5 kDa to 630 kDa, preferably between 5 and 120 kDa, more preferably between 8 and 80 kDa, and cross-linked sulfated galactans with molar masses of 7 kDa and 3000 kDa, preferably between 7 and 1100 kDa, more preferably between 8 and 200 kDa, and (2) a Theobroma cacao L bean hydrolysate, and its use in particular for maintaining the balance of the skin microbiota and promoting and/or improving the wear of make-up.

Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is ?0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.

Abstract: A correlative finding between increased Clostridiales and/or Bifidobacteriales bacterial abundance in the gut and intestinal barrier maturation of preterm neonates at-risk for development of necrotizing enterocolitis (NEC) is disclosed. These findings form the basis for the methods of identifying preterm infants at risk for developing necrotizing enterocolitis (NEC), the methods of treating such infants, as well as the methods of characterizing intestinal permeability in preterm infants disclosed herein.

Abstract: A medical treatment composition, methods for preparation and treatment method are provided. The liquid composition comprises equal parts Sansevieria and ground/blended Cloves. The composition is capable of use in treating and curing cancer. A preparation method may comprise preparing a liquid Sansevieria component, preparing a liquid Clove component, adding the Sansevieria component to the Clove component, and permitting a resulting Sansevieria and ground Clove mixture to sit at room temperature for 24 hours, to provide a liquid medical treatment composition comprising by volume 50% of a Sansevieria component and 50% of a Clove component. Methods of treating cancer may include administering the composition. The present invention also provides liquid pest control compositions comprising equal parts Sansevieria and ground/blended Cloves, and methods for preparation and pest control methods. The pest control compositions and methods may control termites, most particularly drywood termites.

Abstract: A process for obtaining enriched fractions of assets from the genus Artemisia, enriched fractions obtained by the process and bioactive composition having fraction enriched from Artemisia. The process uses extraction with supercritical fluid in which the differential consists of sequential extraction, in an unprecedented association of specific conditions and steps with an advantageous effect not previously found, thus obtaining enriched fractions of bioactives with different chemical compositions for a given application. The enriched fractions of assets of the genus Artemisia and/or its so-called bioactive compositions having fraction enriched from Artemisia obtained have application mainly in the pharmaceutical and cosmetic fields.

Abstract: A method of treating illness is provided by collecting urine of a virgin female camel, performing lyophilization on the urine to form dehydrated urine, forming a medicament using the dehydrated urine as an active ingredient, and administering the medicament to a patient. The medicament can be a nutritional drink, an edible jam, an oral syrup, a suppository, a topical moisturizer, or an injection. The pharmaceutical composition comprises an active ingredient derived from lyophilized urine of a virgin female camel, a pharmaceutical carrier, and one or more additional excipients. The pharmaceutical composition can be used to treat hepatitis B and C, schistosomiasis, fascicola infections, rectal hemorrhoids, and ringworm.

Abstract: A composition and a method for analyzing an anti-aging effect of the composition of a fecal derived sterilized postbiotic are disclosed. The method includes obtaining a baseline biomarker of aging measurement, wherein the baseline biomarker of aging measurement includes a biomarker of aging, selecting a dose schedule from a plurality of dose schedules of a composition for a fecal derived sterilized postbiotic as a function of the baseline biomarker of aging measurement, wherein the composition includes a plurality of biological macromolecules including at least a short chain fatty acid, wherein the short chain fatty acid includes acetic acid, propionic acid, and butyric acid and a plurality of agents, wherein the plurality of agents is configured to regulate the biomarker of aging and administering the composition to a subject.

Abstract: Methods of use and compositions useful for moisturizing skin, conditioning skin, reducing lines and wrinkles, evening skin tone, lightening skin tone, increasing skin radiance, elasticity, skin barrier function, and/or skin firmness, reducing photodamage, reducing sagging skin, increasing anti-oxidant capacity in skin, MMP-1, MMP-3, MMP-9, pro-inflammatory cytokines (e.g., lipoxygenase, IL-6, 11-8, TNF-?, or VEGF), and/or elastase expression in skin, and/or increasing collagen expression in skin, elastin expression in skin, laminin expression in skin, and/or fibronectin expression in skin are disclosed herein. The composition includes a combination of one or more of Rosmarinus officianalis leaf extract, Caulerpa lentillifera extract, Morus alba fruit extract, and Porphyridium cruentum extract.

Abstract: A method of preventing cadmium-induced liver toxicity can include administering an a plant product derived from Achillea millefolium L. to a subject in need thereof. In an embodiment, the plant product is selected from an essential oil of Achillea millefolium L.

Abstract: The present invention provides a synergistic composition that exhibits an anti-proliferative activity, the composition including: therapeutically effective amount of Turmeric (Curcuma spp.); and therapeutically effective amount of Cow urine (Gomutra). The composition comprising a combination of Cow urine and Turmeric extract exhibits unexpected synergistic effect and significantly reduce and/or control the proliferation of cancer cells as compared to Cow urine and Turmeric when used alone.

Abstract: A method of treating skin is disclosed. The method includes topically applying to the skin a composition comprising Lactobacillus ferment, Punica granatum extract, Camellia sinensis leaf extract, Cucumis sativus fruit extract, niacinamide, sodium hyaluronate, glycerin, and butylene glycol, wherein the skin is treated.

Abstract: Disclosed is a method of treating skin with a composition comprising an extract from Magnolia officinalis.

Abstract: Personal care compositions and methods for treating one or more dry skin conditions are disclosed. The composition may include a carrier, one or more plant oils, and a source of Aloe vera. The one or more plant oils and the source of Aloe vera may each be present in an effective amount to increase natural moisturizing factors in skin when applied thereto. The method for treating the one or more dry skin conditions may include contacting the personal care composition with skin. Contacting the personal care composition with the skin may increase an amount of natural moisturizing factors in the skin and/or increase an amount of Caspase-14 in the skin.

Abstract: Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.

Abstract: The present application relates to use for anti-inflammation, and/or for prevention, improvement, and/or treatment of diseases related to vascular dysfunction of Java pepper extract, and provides a composition with an excellent anti-inflammatory effect and/or an excellent effect of prevention, improvement, and/or treatment of diseases related to vascular dysfunction, which is excellent in biosafety, by comprising Java pepper extract.